Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | AGXT | P21549 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2895052 | 0.78 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL28302767 | 0.74 | — | — | |
| SCHEMBL3668208 | 0.74 | — | — | |
| SCHEMBL12408572 | 0.74 | TSHR (0.35) | ALDH1A1POLBMAPTKMT2ACA1 | |
| SCHEMBL258394 | 0.74 | CA4 (0.38) | ALDH1A1POLBMAPTKMT2ACA1 | |
| SCHEMBL28106168 | 0.74 | — | — | |
| SCHEMBL11025852 | 0.73 | TAAR1 (0.36) | IDO1 | |
| SCHEMBL3666357 | 0.72 | CA4 (0.36) | ALDH1A1POLBMAPTKMT2ACA1 | |
| SCHEMBL258618 | 0.72 | CA4 (0.36) | ALDH1A1POLBMAPTKMT2ACA1 | |
| SCHEMBL258694 | 0.72 | LTA4H (0.39) | KMT2ACA1CA2CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2465505-A1 | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | Bayer HealthCare LLC (US) | 2012-06-20 | — | — | EP | disclosed |
| WO-2007064883-A2 | SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | BAYER HEALTHCARE LLC. (US) | 2007-06-07 | — | — | WO | disclosed |